The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 31 (2) , 626-633
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patientsBMC Nephrology, 2013
- Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal DiseaseClinical Journal of the American Society of Nephrology, 2012
- Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysisThe American Journal of Clinical Nutrition, 2012
- Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney DiseaseInternational Journal of Biological Sciences, 2012
- Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and PhosphateCirculation Research, 2011
- Vitamin D Supplementation in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Serum Osteoprotegerin Is a Predictor of Progression of Atherosclerosis and Coronary Calcification in Hemodialysis PatientsNephron Clinical Practice, 2010
- Cholecalciferol Supplementation in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2010
- Cholecalciferol Supplementation Alters Calcitriol-Responsive Monocyte Proteins and Decreases Inflammatory Cytokines in ESRDJournal of the American Society of Nephrology, 2010
- Vitamin D DeficiencyNew England Journal of Medicine, 2007